Contact menu close close AI platform Our team Testimonials Contact us info@cancierge.ai About us Home Benefits For whom

The Leading
AI Platform
for Oncology
& Longevity
arrow_downward Validated treatment options & decision support.

Learn more Learn more Treat cancer effectively.
Increase survival rates.
Treat cancer effectively.
Increase survival rates.
About cancierge® Wer wir sind Wer wir sind Cancer doesn’t wait.
Why should you?
Every year, around 20 million people are diagnosed with cancer – one in five will be affected during their lifetime. Yet many lack fast access to reliable, personalized treatment information: appointments with specialists often take 3 to 6 weeks, and in parts of Europe up to 94 days. During this time, 65% turn to generic, non-validated AI tools for answers.

cancierge® makes this knowledge accessible. As Patients want validated answers at every step, our platform cancierge® delivers it like talking to 100 top tumor board doctors in minutes, and to the specialists who come after them. One platform, from the first answer to the future of their healthy self. CE certification underway.

About cancierge ®
To achieve this, we combine clinical data with oncological expertise to develop an AI-supported platform that assists oncologists in making informed, individualized treatment decisions and offers patients greater guidance throughout the course of treatment.

When a cancer patient asks an AI what the right treatment is, the answer comes from us.
AI platform for tailored support in choosing cancer treatment – developed with key opinion leaders. For patients
Reliable guidance – in minutes, not months.
Individual information on treatment options based on personal medical data
Comprehensible presentation of medical content for discussion with your doctor
Based on guidelines & treatment decisions from comparable patient cases
One platform for the whole way, from the first treatment decision to the future of their healthy self
For clinics More efficient tumor conferences. Better decisions. AI-powered decision support during tumor conferences
Guideline-based, patient-specific therapy recommendations (NCCN, ESMO, AGO)
Support hospitals via clinical trials while collecting valuable Real-World-Data from the hospitals

About cancierge ®
To achieve this, we combine clinical data with oncological expertise to develop an AI-supported platform that assists oncologists in making informed, individualized treatment decisions and offers patients greater guidance throughout the course of treatment.

When a cancer patient asks an AI what the right treatment is, the answer comes from us.
AI platform for tailored support in choosing cancer treatment – developed with key opinion leaders. For patients
Reliable guidance – in minutes, not months.
Individual information on treatment options based on personal medical data
Comprehensible presentation of medical content for discussion with your doctor
Based on guidelines & treatment decisions from comparable patient cases
One platform for the whole way, from the first treatment decision to the future of their healthy self
For clinics More efficient tumor conferences. Better decisions. AI-powered decision support during tumor conferences
Guideline-based, patient-specific therapy recommendations (NCCN, ESMO, AGO)
Support hospitals via clinical trials while collecting valuable Real-World-Data from the hospitals

Your health in best hands Our AI helps you make informed treatment decisions. New approaches to cancer treatment Supporting therapy decisions Current scientific findings, combined with patient data, form the basis for structured and evidence-based treatment options.
 Combination of research, practice, and technology Findings from studies, clinical experience, and AI are continuously incorporated into the decision-making logic. Cancierge® uses AI-powered analytics to provide faster and more informed individualized treatment options for patients. Data security as a fundamental principle
 All medical data is processed in compliance with the GDPR and protected by state-of-the-art infrastructure and security technologies.


Evidence-based
therapy options
01 Supporting patients 02 Optimal use of clinical data 03 Tailored to the individual, based on guidelines 04 Patient-friendly explanations 05 Questions welcome, anytime 06

Daniel Rüben Founder & CEO Daniel is a seasoned entrepreneur with a track record of building, merging and selling software companies, including a sale to a Nasdaq-listed company. At Cancierge® he leads strategy, financing and market expansion. Prof. Dr. med. Sherko Kümmel Prof. Dr. med. Sherko Kümmel is one of Germany’s leading breast cancer surgeons and heads the BreastCenter in Essen. At Cancierge® he leads clinical validation and ensures the product meets medical standards. Our team meet the entire team meet the entire team Prof. Dr. med. Peter Schmid Prof. Dr. med. Peter Schmid is Chair of Cancer Medicine at Queen Mary University of London and lead author of New England Journal of Medicine studies that redefined the standard of care in triple-negative breast cancer. At Cancierge® he guides our scientific direction and evidence strategy. Founder & Medical Lead Founder & Scientific Lead

Creating impact on people´s lives. Creating impact Creating impact on people´s lives. cancierge® on people´s lives. Creating impact on people´s lives. The mind is everything. Creating impact
on people´s lives. cancierge® What you think you become.

How cancierge® is changing cancer treatment

Validated by Leading
Key-Opinion-Leaders

Dr. med. Anna Rüland
Leiterin der Brustzentrum-Sektion, leitende Oberärztin
Fachärztin für Gynäkologie & Geburtshilfe

keyboard_arrow_rightContact us Links keyboard_arrow_rightAbout us AI decision support & deep-medicine for cancer treatment info@cancierge.ai keyboard_arrow_rightFor whom keyboard_arrow_rightBenefits keyboard_arrow_rightAI platform keyboard_arrow_rightOur team keyboard_arrow_rightTestimonials 2026 cancierge. All rights reserved. Data policy Imprint
de_DEen_US